This page contains brief details about the drug , it's indication, dosage & administaration, mechanism of action, related brands with strength, warnings and common side effects.
Background and Date of Approval
Rosuvastatin,Fenofibrate is an antihyperlipidemic drug that belongs to the category of medicines known as statins and fibric acid derivatives. It was approved in 2003 to treat hyperlipidaemia.
Mechanism of Action of undefined
Rosuvastatin works by reducing low density lipoprotein (LDL) levels. It works by slowing down the production of cholesterol, thereby lowering the blood cholesterol levels. By activating the lipoprotein lipase enzyme, the other drug reduces the levels of triglycerides in the blood and thereby lowers the risk of other complications associated with high triglyceride levels. Together, these two medications can help improve lipid profiles and reduce the risk of cardiovascular disease.
Uses of undefined
Rosuvastatin, Fenofibrate has been developed to treat hyperlipidaemia.
undefined Drug administaration and Dosage available
It is an orally available prescription drug. Your doctor will decide the dose and duration of this tablet based on the disease condition and other factors. Always take this medicine as prescribed by your doctor. Do not chew, crush, or break the tablet. Swallow the whole tablet with water.
Warnings, Precautions and Side Effects of undefined
Rosuvastatin,Fenofibrate is contraindicated in patients with known hypersensitivity to rosuvastatin, fenofibrate or any of its components. Also, it should not be used in patients with a history of gallbladder disease including gallstones. It should be used with caution in patients with renal impairment, as it may cause kidney damage. Inform your doctor if you have kidney or liver problems, severe respiratory failure, thyroid problems, continuous muscle pain (such as myopathy or rhabdomyolysis), or if you are drinking heavy amounts of alcohol regularly before starting treatment with Rosuvastatin,Fenofibrate, because it may increase the triglyceride levels in the blood and do not take it unless prescribed by your doctor.
This drug is not recommended during pregnancy as it causes harm to the unborn baby. Avoid getting pregnant and breastfeeding during the treatment. Use effective contraception to avoid pregnancy, as it can harm the developing foetus or nursing infant. It is advised to take a low-cholesterol diet and do regular exercises while taking this medication.
The common side effects that are likely to occur while you are on the treatment with Rosuvastatin, Fenofibrate are headache, muscle pain, constipation, dizziness, weakness and stomach ache. If you experience any allergic or unusual reactions after taking this medicine, report to your doctor immediately.
Word Of Advice
It is highly advised to avoid foods that are high in fat like red meat (beef, lamb, and pork), butter, cheese, sugary drinks, fried foods, and junk foods. Limit your intake of alcohol while taking Rosuvastatin,Fenofibrate, as alcohol can increase your triglyceride levels. A healthy low-fat diet is recommended such as omega-3 fatty acids, which can help to reduce the cholesterol in the blood. Always include foods that are high in nutrients which include berries, apples, broccoli, brown rice, and tofu. If you vomit after taking the medicine, do not take an extra dose. Take your next dose at the regular time. Do not stop taking this medicine without talking to your doctor. Your doctor may do lab tests to check the therapy's effectiveness or monitor the unwanted side effects.
Frequently Asked Question
- AstraZeneca UK Ltd, Electronic Medicines Compendium (EMC), [Revised on July 2022] [Accessed on 20th April 2023], https://www.medicines.org.uk/emc/files/pil.6779.pdf
- Glenmark Pharmaceuticals Europe Limited, Electronic Medicines Compendium (EMC), [Revised on October 2021] [Accessed on 20th April 2023], https://www.medicines.org.uk/emc/files/pil.9971.pdf
- Zentiva Pharma UK Limited, , Electronic Medicines Compendium (EMC), [Revised on June 2022] [Accessed on 20th April 2023], https://www.medicines.org.uk/emc/files/pil.8870.pdf
- Goodman & Gilman’s Pharmacological Basis of Therapeutics, 13th Edition, 2018, 905-909.
The drug information on this page is not a substitute for medical advice, it is meant for educational purposes only. For further details consult your doctor about your medical condition to know if you are eligible to receive this treatment.